News-Medical.Net June 29, 2022
Reviewed by Emily Henderson, B.Sc.

A joint research group led by Genki Kanda at the RIKEN Center for Biosystems Dynamics Research (BDR) has developed a robotic artificial intelligence (AI) system for autonomously determining the optimal conditions for growing replacement retina layers necessary for vision.

The AI controlled a trial and error process spanning 200 million possible conditions that succeeded in improving cell culture recipes used in regenerative medicine. This achievement, published in the scientific journal eLife on June 28, is just one example of how the automated design and execution of scientific experiments can increase the efficiency and speed of life science research in general.

Research in regenerative medicine often requires numerous experiments that are both time-consuming and labor-intensive. In particular, creating specific tissue from...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: AI (Artificial Intelligence), Provider, Robotics/RPA, Technology
Related Articles:
Apple to open AI server factory in Texas as part of $500 billion U.S. investment
Nvidia will face off with investors demanding perfection as the ‘spigot of investment dollars’ gushes into AI
Microsoft Refutes Reports of AI Infrastructure Pullback
Nvidia Invests Further Into Healthcare And Releases The Largest Biology Foundation Model With The Arc Institute
How To Prop Up Human IP In The AI Age

Share This Article